Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Ambros IM, Ambros PF (1995) Schwann cells in neuroblastoma. Eur J Cancer 31A:429–434
Biedler JL, Spengler BA, Chang T-D, Ross RA (1988) Transdifferentiation of human neuroblastoma cells results in coordinate loss of neuronal and malignant properties. In: Evans AE, D'Angio GJ, Knudson AG, Seeger RC (eds) Advances in neuroblastoma research, vol 2. Liss, New York, pp 265–276
Biedler JL, Spengler BA, Ross RA (1997) Human neuroblastoma cell differentiation. In: Raghavan D, Scher HI, Leibel SA, Lange PH (eds) Principles and practice of genitourinary oncology. Lippincott-Raven, Philadelphia, pp 1053–1061
Brodeur GM (2003) Neuroblastoma: biological insights into a clinical enigma. Nat Rev Cancer 3:203–216
Cohen N, Betts DR, Rechavi G, Amariglio N, Trakhtenbrot L (2003) Clonal expansion and not cell interconversion is the basis for the neuroblast and nonneuronal types of the SK-N-SH neuroblastoma cell line. Cancer Genet Cytogenet 143:80–84
Hemmati HD, Nakano I, Lazareff JA, Masteman-Smith M, Geschwind DH, Bronner-Fraser M, Kornblum HI (2003) Cancerous stem cells can arise from pediatric brain tumors. Proc Natl Acad Sci USA 100:15178–15183
Huang D, Rutkowski JL, Brodeur GM, Chou PM, Kwiatkowski JL, Babbo A, Cohn SL (2000) Schwann cell-conditioned medium inhibits angiogenesis. Cancer Res 60:5966–5971
Jessen KR, Mirsky R (1999) Schwann cells and their precursors emerge as major regulators of nerve development. Trends Neurosci 22:402–410
Jögi A, Øra I, Nilsson H, Lindeheim Å, Makino Y, Poellinger L, Axelson H, Påhlman S (2002) Hypoxia alters gene expression in human neuroblastoma cells toward an immature and neural crest-like phenotype. Proc Natl Acad Sci USA 99:7021–7026
Kwiatkowski JL, Rutkowski JL, Yamashiro DJ, Tennekoon GI, Brodeur GM (1998) Schwann cell-conditioned medium promotes neuroblastoma survival and differentiation. Cancer Res 58:4602–4606
Le Douarin NM, Ziller C (1993) Plasticity in neural crest differentiation. Curr Opin Cell Biol 5:1036–1043
Liu Y, Rao MS (2003) Transdifferentiation: fact or artifact. J Cell Biochem 88:29–40
Lo L, Dormand E, Greenwood A, Anderson DJ (2002) Comparison of the generic neuronal differentiation and neuron subtype specification functions of mammalian achaetescute and atonal homologs in cultured neural progenitor cells. Development 129:1553–1567
Luo R, Gao J, Wehrle-Haller B, Henion PD (2003) Molecular identification of distinct neurogenic and melanogenic neural crest sublineages. Development 130:321–330
Mascorro JA, Yates RD (1989) Mitotic cell division in the extraadrenal chromaffin system of various species. J Electron Microsc Tech 12:323–330
Mora J, Cheung N-K, Juan G, Illei P, Cheung I, Akram M, Ladanyi M, Cordon-Cardo C, Gerald WL (2001) Neuroblastic and Schwannian stromal cells of neuroblastoma are derived from a tumoral progenitor cell. Cancer Res 61:6892–6898
Rettig WJ, Spengler BA, Garin Chesa PG, Old LJ, Biedler JL (1987) Coordinate changes in neuronal phenotype and surface antigen expression in human neuroblastoma cell variants. Cancer Res 47:1383–1389
Ross RA, Biedler JL (1985) Presence and regulation of tyrosinase activity in human neuroblastoma cell variants in vitro. Cancer Res 45:1628–1638
Ross RA, Spengler BA, Domènech C, Porubcin M, Rettig WJ, Biedler JL (1995) Human neuroblastoma I-type cells are malignant neural crest stem cells. Cell Growth Differ 6:449–456
Ross RA, Hein AM, Braca III, JA, Spengler BA, Biedler JL, Scammell JG (2002) Glucocorticoids induce neuroendocrine cell differentiation and increase expression of N-MYC in N-type human neuroblastoma cells. Oncol Res 13:87–94
Ross RA, Biedler JL, Spengler BA (2003) The role of distinct cell types in regulation of malignancy in human neuroblastoma cell lines and tumors. Cancer Lett 197:35–39
Shimada H, Ambros IM, Dehner LP, Hata J-i, Joshi VV, Roald B (1999) Terminology and morphologic criteria of neuroblastoma tumors. Cancer 86:349–363
Spengler BA, Ross RA, Biedler JL (1986) Differential drug sensitivity of human neuroblastoma cells. Cancer Treat Rep 70:959–965
Spengler BA, Lazarova DL, Ross RA, Biedler JL (1997) Cell lineage and differentiation state are primary determinants of MYCN gene expression and malignant potential in human neuroblastoma cells. Oncol Res 9:467–476
Sugimoto T, Mine H, Horii Y, Takahashi K, Nagai R, Morishita R, Komada M, Asada Y, Sawada T (2000) Neuroblastoma cell lines showing smooth muscle cell phenotypes. Diagn Mol Pathol 9:221–228
Thomas SK (2003) Nestin is a potential mediator of malignancy in human neuroblastoma cells. PhD dissertation, Fordham University, New York
Tsokos M, Scarpa S, Ross RA, Triche TJ (1987) Differentiation of human neuroblastoma recapitulates neural crest development. Am J Pathol 3:484–496
Valent A, Bénard J, Venuat, A-M, da Silva J, Duverger A, Duarte N, Hartmann O, Spengler BA, Bernheim A (1999) Phenotypic and genotypic diversity of human neuroblastoma studies in three IGR cell line models derived from bone marrow metastases. Cancer Genet Cytogenet 112:124–129
Walton JD, Kattan DR, Thomas SK, Spengler BA, Guo H-F, Biedler JL, Cheung N-KV, Ross RA (2004) Characteristics of stem cells from human neuroblastoma cell lines and in tumors. Neoplasia 6: in press
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Ross, R.A. (2005). Cellular Heterogeneity. In: Cheung, NK.V., Cohn, S.L. (eds) Neuroblastoma. Pediatric Oncology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-26616-X_6
Download citation
DOI: https://doi.org/10.1007/3-540-26616-X_6
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-40841-3
Online ISBN: 978-3-540-26616-7
eBook Packages: MedicineMedicine (R0)